Rouan Sarah Kathryn - Insider Non-Derivative Transactions at Viking Therapeutics, Inc. (VKTX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Feb 8, 2024, Rouan Sarah Kathryn's relationship to Viking Therapeutics, Inc. (VKTX) is Director, and currently has 25,000 shares of Common Stock, par value $0.00001 per share.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other VKTX insiders.
Data Source: SEC.
Rouan Sarah Kathryn - Insider Non-Derivative Transactions of VKTX Common Stock, par value $0.00001 per share
Rouan Sarah Kathryn - Insider Non-Derivative Transactions at VKTX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Feb 9, 2024 | Sell -- (Common Stock, par value $0.00001 per share) | 25000 | 28.05 | 0 |
| Feb 9, 2024 | M -- (Common Stock, par value $0.00001 per share) | 25000 | 8.32 | 25000 |
| Jan 20, 2024 | Sell -- (Common Stock, par value $0.00001 per share) | 30000 | 23.05 | 0 |
| Jan 20, 2024 | M -- (Common Stock, par value $0.00001 per share) | 30000 | 8.32 | 30000 |